Home
Mail
Search
News
Finance
Sport
Lifestyle
Celebrity
Movies
Weather
Mobile
More
Yahoo
Mail
Cryptocurrencies
News
Property
Money
Markets
Industries
Watchlists
My Portfolio
My Screeners
Singapore markets closed
Straits Times Index
3,280.10
-7.65
(-0.23%)
Nikkei
37,934.76
+306.28
(+0.81%)
Hang Seng
17,651.15
+366.61
(+2.12%)
FTSE 100
8,139.83
+60.97
(+0.75%)
Bitcoin USD
63,212.56
-687.84
(-1.08%)
CMC Crypto 200
1,304.48
-92.06
(-6.59%)
Kiniksa Pharmaceuticals, Ltd. (KNSA)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
17.88
+0.27
(+1.53%)
At close: 04:00PM EDT
17.88
0.00
(0.00%)
After hours:
04:02PM EDT
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
270,259
270,259
220,180
38,544
0
Cost of revenue
89,931
33,407
22,895
9,100
0
Gross profit
180,328
236,852
197,285
29,444
0
Operating expenses
Research development
76,097
76,097
65,490
99,297
112,042
Selling general and administrative
129,427
129,427
97,951
85,948
45,321
Total operating expenses
205,524
262,048
187,512
186,080
157,363
Operating income or loss
-25,196
-25,196
9,773
-156,636
-157,363
Total other income/expenses net
8,544
8,544
1,253
97
-
Income before tax
-16,652
-16,652
11,026
-156,539
-156,229
Income tax expense
-30,736
-30,736
-172,337
1,385
5,152
Income from continuing operations
14,084
14,084
183,363
-157,924
-161,381
Net income
14,084
14,084
183,363
-157,924
-161,381
Net income available to common shareholders
14,084
14,084
183,363
-157,924
-161,381
Basic EPS
-0.10
-
2.64
-2.30
-2.61
Diluted EPS
-0.11
-
2.60
-2.30
-2.61
Basic average shares
69,868
-
69,382
68,577
61,843
Diluted average shares
70,172
-
70,421
68,577
61,843
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.